SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-054995
Filing Date
2010-03-12
Accepted
2010-03-12 12:48:26
Documents
7
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1130580
2 SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 2008
3 CONSENT OF ERNST & YOUNG LLP dex231.htm EX-23.1 1822
4 PEO & PFO CERTIFICATION PURSUANT TO SECTION 302 dex311.htm EX-31.1 6914
5 PEO & PFO CERTIFICATION PURSUANT TO SECTION 906 dex321.htm EX-32.1 3210
6 GRAPHIC g90961g68t45.jpg GRAPHIC 48689
7 GRAPHIC g90961g74j09.jpg GRAPHIC 46038
  Complete submission text file 0001193125-10-054995.txt   1276954
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31141 | Film No.: 10676728
SIC: 2834 Pharmaceutical Preparations